BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27698010)

  • 1. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
    Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
    J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.
    Lokau J; Wandel M; Garbers C
    Int J Biochem Cell Biol; 2017 Apr; 85():6-14. PubMed ID: 28143719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.
    Yan I; Schwarz J; Lücke K; Schumacher N; Schumacher V; Schmidt S; Rabe B; Saftig P; Donners M; Rose-John S; Mittrücker HW; Chalaris A
    J Leukoc Biol; 2016 May; 99(5):749-60. PubMed ID: 26561568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.
    Garbers C; Jänner N; Chalaris A; Moss ML; Floss DM; Meyer D; Koch-Nolte F; Rose-John S; Scheller J
    J Biol Chem; 2011 Apr; 286(17):14804-11. PubMed ID: 21454673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
    McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
    J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
    Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
    J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
    Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
    Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 trans-signaling is another pathway to upregulate Osteopontin.
    Uchibori T; Matsuda K; Shimodaira T; Sugano M; Uehara T; Honda T
    Cytokine; 2017 Feb; 90():88-95. PubMed ID: 27863335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling.
    Flynn CM; Garbers Y; Lokau J; Wesch D; Schulte DM; Laudes M; Lieb W; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2019 May; 9(1):7306. PubMed ID: 31086276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro.
    Flynn CM; Garbers Y; Düsterhöft S; Wichert R; Lokau J; Lehmann CHK; Dudziak D; Schröder B; Becker-Pauly C; Rose-John S; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2020 Dec; 10(1):21612. PubMed ID: 33303781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.
    Briso EM; Dienz O; Rincon M
    J Immunol; 2008 Jun; 180(11):7102-6. PubMed ID: 18490707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
    Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
    Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
    Chalaris A; Rabe B; Paliga K; Lange H; Laskay T; Fielding CA; Jones SA; Rose-John S; Scheller J
    Blood; 2007 Sep; 110(6):1748-55. PubMed ID: 17567983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation.
    Rose-John S
    Clin Pharmacol Ther; 2017 Oct; 102(4):591-598. PubMed ID: 28675418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
    Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
    Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells.
    Schumacher N; Thomsen I; Brundert F; Hejret V; Düsterhöft S; Tichý B; Schmidt-Arras D; Voss M; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119489. PubMed ID: 37271223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.